Agios Pharmaceuticals (AGIO) Revenue Growth (3y) (2015 - 2026)
Agios Pharmaceuticals (AGIO) Revenue Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,071.81 Bn | - | - |
| 2 | Nanobiotix | 1,925.70 Bn | 1,925.64 Bn | - | - |
| 3 | Akari Therapeutics | 1,062.88 Bn | 1,062.88 Bn | - | - |
| 4 | BeOne Medicines | 469.09 Bn | 464.29 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 123.09 Bn | 115.84 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 70.32 Bn | 61.57 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 63.36 Bn | 63.36 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.71 Bn | 1.41 Bn | 79.44% |
| 9 | Alnylam Pharmaceuticals | 37.69 Bn | 34.68 Bn | 959.66 Mn | 54.05% |
| 10 | Agios Pharmaceuticals | 2.23 Bn | 1.49 Bn | 19.43 Mn | 54.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.65% |
| Dec 31, 2025 | 66.70% |
| Sep 30, 2025 | 54.15% |
| Jun 30, 2025 | 30.67% |
| Mar 31, 2025 | 118.89% |
| Dec 31, 2023 | -45.57% |
| Sep 30, 2023 | -40.26% |
| Jun 30, 2023 | -43.57% |
| Mar 31, 2023 | -59.92% |
| Dec 31, 2022 | -50.46% |
| Sep 30, 2022 | -48.69% |
| Jun 30, 2022 | -40.29% |
| Mar 31, 2022 | -69.81% |
| Dec 31, 2020 | 65.03% |
| Sep 30, 2020 | 45.11% |
| Dec 31, 2019 | 16.10% |
| Sep 30, 2019 | 42.55% |
| Jun 30, 2019 | 55.47% |
| Mar 31, 2019 | -1.14% |
| Dec 31, 2018 | 58.06% |